Noncompliance is an impact factor in the treatment of gastroesophageal reflux disease

References

• Dent J, El-Serag HB, Wallander MA, et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005;54:710-17
   PubMed Web of Science ®Google Scholar
• Moraes-Filho JPP, Chinzon D, Eisig JN, et al. Prevalence of heartburn and gastroesofageal reflux disease in the urban brazilian population. Arq Gastroenterol 2005;42(2):122-7
   PubMedGoogle Scholar
• Wong BC, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol 2006;4:398-407
   PubMed Web of Science ®Google Scholar
• Mönnikes H, Schwan T, van Rensburg C, et al. Possible etiology of improvements in both quality of life and overlapping gastroesophageal reflux disease by proton pump inhibitor treatment in a prospective randomized controlled trial. BMC Gastroenterol 2013;13:145-54
   Google Scholar
• Bolier EA, Kessing BF, Smout AJ, et al. Systematic review: questionnaires for assessment of gastroesophageal reflux disease. Dis Esophagus 2013. [Epub ahead to print]
   PubMedGoogle Scholar
• Mody R, Eisenberg D, Hou L, et al. Comparison of health care resource utilization and costs among patients with GERD on once-daily or twice-daily proton pump inhibitor therapy. Clinicoecon Outcomes Res 2013;5:161-9
   PubMedGoogle Scholar
• Picardo SL, O’Brien MP, Feighery R, et al. A Barrett´s esophagus registry over 1000 patients from a specialist center highlights greater risk of progression than population-based registries and high risk low grade dyplasia. Dis Esophagus 2014. [Epub ahead to print]
   PubMedGoogle Scholar
• Katz PO, Gerson LB, Vela MF. Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am J Gastroenterol 2013;108:308-28
   PubMed Web of Science ®Google Scholar
• Fass R, Gasiorowska A. Refractory GERD: what is it? Curr Gastroenterol Rep 2013;10:252-7
   Google Scholar
• Kahrilas PJ, Boeckxstaens G, Smout AJ, et al. Management of patients with incomplete response to PPI therapy. Best Pract Res Clin Gastroenterol 2013;27:401-14
   PubMed Web of Science ®Google Scholar
• Sabaté E. Adherence to long-term therapies: evidence for action. WHO, Geneva, Switzerland; 2003. Available from: www.who.int/chp/knowledge/publications/adherence_report/en/ [Last accessed 8 Jan 2007]
   Google Scholar
• DiMatteo MR, Giordani PJ, Lepper HS, et al. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 2002;40:794-811
   PubMed Web of Science ®Google Scholar
• Fass R, Shapiro M, Dekel R, et al. Systematic review: proton pump inhibitor failure in gastro-esophageal reflux disease – where next? Aliment Pharmacol Ther 2005;22:79-94
   PubMed Web of Science ®Google Scholar
• Moraes-Filho JPP. Refractory Gastroesophageal reflux disease. Arq Gastroenterol 2012;49:296-301
   PubMedGoogle Scholar
• El Serag HB, Fitzgerald S, Richardson P. The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study. Am J Gastroenterol 2009;104:2161-77
   PubMedGoogle Scholar
• Hoogendoorn RJ, Groeneveld L, Kwee JA. Patient satisfaction with switching to esomeprazole from existing proton pump inhibitor therapy for gastro-oesophageal reflux disease: an observational, multicentre study. Clin Drug Investig 2009;29:803-10
   PubMedGoogle Scholar
• Robinson M, Shaw K. Proton pump inhibitor attitudes and usage: a patient survey. Pharmacol Ther J 2002;27:202-6
   Google Scholar
• Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74
   PubMed Web of Science ®Google Scholar
• Dal-Paz K, Moraes-Filho JPP, Navarro-Rodriguez T, et al. Low levels of adherence with proton pump inhibitor therapy contribute to therapeutic failure in gastroesophageal reflux disease. Dis Esophagus 2012;25:107-13
   PubMed Web of Science ®Google Scholar
• Gosselin A, Luo R, Lohoues H, et al. The impact of proton pump inhibitor compliance on health-care resource utilization and costs in patients with gastroesophageal reflux disease. Value Health 2009;12:34-9
   PubMed Web of Science ®Google Scholar
• Hungin APS, Hill C, Mollody-Bland M, Raghunath A. Systematic Review: patterns of proton pump inhibitor. use and adherence in gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2012;10:109-16
   PubMed Web of Science ®Google Scholar
• Hall J, Dodd S, Durkin M, et al. Impact of proton pump inhibitor utilization patterns on gastroesophageal reflux disease-related costs. Manag Care 2002;11(7 suppl):14-118
   PubMedGoogle Scholar
• Chey WD, Mody RR, Wu EQ, et al. Treatment patterns and symptom control in patients with GERD: US community-based survey. Curr Med Res Opin 2009;25:1869-78
   PubMed Web of Science ®Google Scholar
• Moraes-Filho JP, Navarro-Rodriguez T, Eisig JN, et al. Comorbidities are frequent in patients with gastroesophageal reflux disease in a tertiary health care hospital. Clinics 2009;64:785-90
   PubMed Web of Science ®Google Scholar
• Van Soest EM, Siersema PD, Dieleman JP, et al. Persistence and adherence to proton pump inhibitors in daily clinical practice. Aliment Pharmacol Ther 2006;24:377-85
   PubMed Web of Science ®Google Scholar
• Dilla T, Valladares A, Lizan L, et al. Adherencia y persistencia terapeutica: causas, consecuencias y estrategias de mejora. Aten Primaria 2009;41:342-8
   PubMedGoogle Scholar
• Van Wijk BL, Klungel OH, Heerdink ER, et al. Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review. Ann Pharmacother 2005;39:319-28
   PubMed Web of Science ®Google Scholar
• Barrison AF, Jarboe LA, Weinberg BM, et al. Patterns of proton pump inhibitor use in clinical practice. Am J Med 2001;111:469-73
   PubMed Web of Science ®Google Scholar
• Richter J. How to manage refractory GERD. Nat Clin Pract Gastroenterol Hepatol 2007;4:658-64
   PubMedGoogle Scholar
• Kamolz T. Analysis of medical compliance in gastro-oesophageal reflux disease patients referred to pre-surgical examination. Dig Liver Dis 2002;34:183-9
   PubMedGoogle Scholar
• Sifrim D, Zerbib F. Diagnosis and management. of patients with reflux symptoms refractory to proton pump inhibitors. Gut 2012;61:1340-54
   PubMed Web of Science ®Google Scholar
• Wileman SM, McCann S, Grant AM, et al. Medical versus surgical management for gastro-oesophageal reflux disease (GORD) in adults. Cochrane Database Syst Rev 2010(3):CD003243
   Google Scholar